Research location
Rohtak
Haryana, India
Advertisement
Research activity in Rohtak
Haryana, IndiaCureCurrent currently publishes aggregate city-level research activity for this location: 22 trials and 23 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Rohtak
22 linked trials · page 1 of 1Complete Pulpotomy and Root Canal Treatment Patients With Irreversible Pulpitis With Type 2 Diabetes MellitusNCT07163975 · 2025-05-01 · 1 site observation
RECRUITING
A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)NCT05865002 · 2023-09-05 · 1 site observation
RECRUITING
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPDNCT06981078 · 2025-07-02 · 1 site observation
ACTIVE_NOT_RECRUITING
(DDS) in India: a Screening Tool to Identify Prediabetes and Undiagnosed Type 2 Diabetes in Dental SettingsNCT06453278 · 2024-09-01 · 1 site observation
UNKNOWN
Outcome of Complete Pulpotomy in Healthy and Type 2 Diabetic Patients in Permanent Teeth With Irreversible PulpitisNCT06586775 · 2023-08-01 · 1 site observation
COMPLETED
Association of Apical Periodontitis With Systemic Level of Inflammatory Markers : A Longitudinal Intervention StudyNCT05814965 · 2023-04-05 · 1 site observation
UNKNOWN
Safety and Efficacy of Inhaled Sedation in Management of Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseNCT07191470 · 2023-04-01 · 1 site observation
COMPLETED
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)NCT05813288 · 2023-03-27 · 1 site observation
TERMINATED
Effect of NSRCT on HbA1c and Inflammatory Markers in Healthy and Type 2 Diabetes Patients With Apical PeriodontitisNCT05609747 · 2021-12-27 · 2 site observations
UNKNOWN
An Indian Post Marketing Study of Mealtime Insulin, Fiasp®, to Evaluate Its Safety and Effectiveness in Patients With Diabetes Mellitus in Routine Clinical PracticeNCT03987802 · 2021-01-20 · 1 site observation
COMPLETED
Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily in People With Type 2 DiabetesNCT04707469 · 2021-01-15 · 1 site observation
COMPLETED
A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin BeforeNCT04460885 · 2020-11-25 · 1 site observation
COMPLETED
Preventing Adverse Cardiac Events in COPDNCT03917914 · 2020-06-30 · 1 site observation
COMPLETED
An Observational Study to Assess the Prevalence of Heart Failure in Type 2 Diabetes PatientsNCT04072523 · 2019-12-03 · 1 site observation
COMPLETED
A Heart Disease Study of Semaglutide in Patients With Type 2 DiabetesNCT03914326 · 2019-06-17 · 1 site observation
COMPLETED
Effect of Primary Non-surgical Endodontic Therapy on Glycaemic Control in Type 2 Diabetic Patients With Asymptomatic Apical PeriodontitisNCT05170880 · 2019-02-11 · 1 site observation
COMPLETED
STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or ObesityNCT03548935 · 2018-06-04 · 1 site observation
COMPLETED
Indian Phenotype RegistryNCT03363594 · 2017-12-11 · 1 site observation
COMPLETED
Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 DiabetesNCT03136484 · 2017-03-15 · 1 site observation
COMPLETED
Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 DiabetesNCT02500706 · 2016-05-04 · 1 site observation
COMPLETED
A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes MellitusNCT02501161 · 2016-01-31 · 1 site observation
COMPLETED
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 DiabetesNCT01617434 · 2012-09-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.